A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Phase 1 – testing safety in a small group of people
Conditions:
Diabetes Mellitus
Sponsor: Addpharma Inc.
trial.available_in:
БГ
Overview
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Who can participate
Inclusion Criteria:
* Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
* The Age equal to or greater than 19 in healthy volunteers at the time of screening visit
Exclusion Criteria:
* Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
* Other exclusions applied
БГ